Isophilic immune response was profoundly depressed in rats injected with heterophilic antigen during the first week of life and challenged with sheep red cells 10 to 18 weeks later. Untreated litter mates served as controls. When neonatal treatment was given during the second week of life and/or challenge with sheep red cells was deferred until 20 weeks, the isophilic immune response was inhibited to a lesser degree. Rats injected neonatally with sheep red cells had decreased amounts of isophilic and heterophilic antibodies upon challenge with sheep red cells 12 weeks later, while intervals of 16 to 20 weeks between neonatal treatment and adult immunization with sheep red cells increased heterophilic antibodies without significant changes in isophilic antibodies. Rats exposed neonatally to either heterophilic antigen or sheep red cells, and challenged with heterophilic antigen as adults, formed significantly more heterophilic antibodies than did control litter mates. These observations were interpreted as resulting from imprinting of large numbers of cells with receptors for heterophilic antigen after neonatal exposure to the antigen, and cellular diversion of antigen upon challenge of adult animals with sheep red cells. The possible relationship of this phenomenon to the interference with Rh immunization of ABO incompatibility in man was considered.

Keywords:
Immune response, Neonatal exposure to antigens, Isophilic antibodies, Heterophilic antigens, Heterophilic antibodies, Rh immunization and ABO incompatibility
This content is only available via PDF.
1970
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.